HCC
Clinical trials for HCC explained in plain language.
Never miss a new study
Get alerted when new HCC trials appear
Sign up with your email to follow new studies for HCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer patients who run out of options
Disease control OngoingThis study is testing the drug cabozantinib for people with advanced liver cancer (hepatocellular carcinoma) whose tumors have continued to grow despite treatment with immunotherapy drugs. The goal is to see if cabozantinib can help control the cancer, slow its progression, and e…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: Stephen Chan Lam • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for liver cancer patients Who've run out of options
Disease control OngoingThis study is testing whether a new drug called pracytarabine works better than the existing drug regorafenib for people with advanced liver cancer that has stopped responding to standard treatments. It will involve 60 adults whose cancer has continued to grow despite previous th…
Matched conditions: HCC
Phase: PHASE2, PHASE3 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Immune therapy trial targets Virus-Linked liver tumors
Disease control OngoingThis study tests the immunotherapy drug pembrolizumab in 30 patients with advanced liver cancer caused by chronic hepatitis B infection. Researchers will give the drug every three weeks and take tumor samples before and during treatment to study how the immune system responds. Th…
Matched conditions: HCC
Phase: PHASE2 • Sponsor: CCTU • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC